Skip to main content
. Author manuscript; available in PMC: 2012 Jul 15.
Published in final edited form as: J Immunol. 2011 Jun 15;187(2):1023–1030. doi: 10.4049/jimmunol.1004195

Figure 4. Anti-HLA antibodies are equally prevalent in those with and without CAV.

Figure 4

Sera from 40 patients with CAV and 32 patients without CAV were screened for the presence of anti-HLA antibodies using luminex. There was no statistically significant difference in percentage of patients who screened positive for class I alone, class II alone, class I and class II, or either class I or II between the two groups. p=ns for all groups.